Nurix Therapeutics, Inc.
NRIXUnited States
25 filed reports · 295 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
25 reports · Aug 2020 to Aug 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 14 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 19 | 2,438 | Aug 2020 to Aug 2026 |
| Annual · 10-KSEC EDGAR | 6 | 2,026 | Nov 2020 to Nov 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q3 | 10-Q | Aug 31, 2026 | Oct 13, 2026 | 340 | Open |
| FY2026 Q2 | 10-Q | May 31, 2026 | Jul 9, 2026 | 162 | Open |
| FY2026 Q1 | 10-Q | Feb 28, 2026 | Apr 8, 2026 | 163 | Open |
| FY2025 | 10-K | Nov 30, 2025 | Jan 28, 2026 | 617 | Open |
| FY2025 Q3 | 10-Q | Aug 31, 2025 | Oct 9, 2025 | 133 | Open |
| FY2025 Q2 | 10-Q | May 31, 2025 | Jul 9, 2025 | 102 | Open |
| FY2025 Q1 | 10-Q | Feb 28, 2025 | Apr 8, 2025 | 100 | Open |
| FY2024 | 10-K | Nov 30, 2024 | Jan 28, 2025 | 306 | Open |
| FY2024 Q3 | 10-Q | Aug 31, 2024 | Oct 11, 2024 | 133 | Open |
| FY2024 Q2 | 10-Q | May 31, 2024 | Jul 11, 2024 | 96 | Open |
| FY2024 Q1 | 10-Q | Feb 29, 2024 | Apr 10, 2024 | 105 | Open |
| FY2023 | 10-K | Nov 30, 2023 | Feb 15, 2024 | 194 | Open |
Financial data
295 concepts · 4,464 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial293 concepts · 4,376 facts · Nov 2017 to Aug 2026
- Stockholders equity (US GAAP)40 · Nov 2018 to Aug 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value38 · Feb 2019 to Aug 2026
- Net income loss38 · Feb 2019 to Aug 2026
- Revenue38 · Feb 2019 to Aug 2026
- Stock issued during period value stock options exercised38 · Feb 2019 to Aug 2026
- Cash and cash equivalents at carrying value36 · Nov 2018 to Aug 2026
- Cash cash equivalents restricted cash and restricted cash equivalents36 · Nov 2018 to Aug 2026
- Comprehensive income net of tax36 · Aug 2019 to Aug 2026
- Depreciation and amortization36 · Aug 2019 to Aug 2026
- General and administrative expense (US GAAP)36 · Aug 2019 to Aug 2026
- Income tax expense benefit36 · Aug 2019 to Aug 2026
- Interest and other income36 · Aug 2019 to Aug 2026
- Operating expenses (US GAAP)36 · Aug 2019 to Aug 2026
- Operating income loss36 · Aug 2019 to Aug 2026
- Operating lease expense36 · Aug 2019 to Aug 2026
- Other comprehensive income loss available for sale securities adjustment net of tax36 · Feb 2019 to Aug 2026
- Research and development expense36 · Aug 2019 to Aug 2026
- Restricted cash noncurrent36 · Nov 2018 to Aug 2026
- Accretion amortization of discounts and premiums investments35 · Nov 2019 to Aug 2026
- Capital expenditures incurred but not yet paid35 · Nov 2019 to Aug 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect35 · Nov 2019 to Aug 2026
- Debt securities available for sale continuous unrealized loss position12 months or longer number of positions35 · Nov 2019 to Aug 2026
- Increase decrease in accounts payable35 · Nov 2019 to Aug 2026
- Increase decrease in contract with customer liability35 · Nov 2019 to Aug 2026
Segment1 concepts · 50 facts · Nov 2023 to Aug 2026
- Research and development expense50 · Nov 2023 to Aug 2026
Product1 concepts · 38 facts · May 2022 to Aug 2026
- Revenue38 · May 2022 to Aug 2026
Segments
88 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 50 facts
- Reportable50 · Nov 2023 to Aug 2026
Product or service2 members · 38 facts
- Collaboration Revenue20 · May 2022 to Aug 2026
- License Revenue18 · May 2022 to Aug 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary11 claims from 1 reports · Aug 2026
- Management discussion (MD&A) commentary14 claims from 1 reports · Aug 2026
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.